
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling
Author(s) -
Dominique Figarella-Branger,
Emmanuèle Lechapt,
Émeline Tabouret,
Stephanie T. Jünger,
A. Maues de Paula,
Corinne Bouvier,
Carole Colin,
Anne Jouvet,
Fabien Forest,
Felipe Andreiuolo,
Isabelle QuintinRoué,
MarieChristine Machet,
Anne Heitzmann,
Serge Milin,
Henri Sevestre,
Catherine Godfraind,
François Labrousse,
Philippe Métellus,
Didier Scavarda,
Torsten Pietsch
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now025
Subject(s) - biology , ependymoma , pathology , histogenesis , pathological , immunohistochemistry , cancer research , medicine , immunology
Clear cell ependymoma is one of the 4 main histological subtypes of ependymomas defined by the World Health Organization (WHO) classification of tumors of the CNS. DNA methylation profiling can distinguish 4 subgroups of intracranial ependymomas, including supratentorial (ST) ependymomas with Yes-associated protein 1 fusion (YAP1), ST ependymomas with fusion of v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA), posterior fossa ependymomas with balanced genome, and posterior fossa ependymomas with chromosomal instability. In addition, trisomy 19 is a genomic hallmark of ependymomas with rich branching capillaries. However, the relation of histological and molecular subtypes is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom